Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries
The DOI matches its Crossref record, with a small difference in title or year; 39 of the 45 references it cites were found in a registry or an index.
Abstract
Background The large observed variability in hemophilia prevalence prevents robust estimation of burden of disease. Objective To estimate the prevalence and prevalence at birth of hemophilia and the associated life expectancy disadvantage. Design Random-effects meta-analysis of registry data. Setting Australia, Canada, France, Italy, New Zealand, and the United Kingdom. Participants Male patients with hemophilia A or B. Measurements Prevalence of hemophilia as a proportion of cases to the male population, prevalence of hemophilia at birth as a proportion of cases to live male births by year of birth, life expectancy disadvantage as a 1 - ratio of prevalence to prevalence at birth, and expected number of patients worldwide based on prevalence in high-income countries and prevalence at birth. Results Prevalence (per 100 000 males) is 17.1 cases for all severities of hemophilia A, 6.0 cases for severe hemophilia A, 3.8 cases for all severities of hemophilia B, and 1.1 cases for severe hemophilia B. Prevalence at birth (per 100 000 males) is 24.6 cases for all severities of hemophilia A, 9.5 cases for severe hemophilia A, 5.0 cases for all severities of hemophilia B, and 1.5 cases for severe hemophilia B. The life expectancy disadvantage for high-income countries is 30% for hemophilia A, 37% for severe hemophilia A, 24% for hemophilia B, and 27% for severe hemophilia B. The expected number of patients with hemophilia worldwide is 1 125 000, of whom 418 000 should have severe hemo…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HA and hemophilia B (HB) are X-linked monogenic disorders resulting from decreased/absent function of coagulation FVIII or FIX.165,166”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [165]
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Random-effects model for meta-analysis of clinical trials: An update
DerSimonian, R., & Kacker, R. (2007) · Contemporary Clinical Trials · doi:10.1016/j.cct.2006.04.004 · Cited by 2,374
Evidence-based health policy—lessons from the Global Burden of Disease Study
Murray, C. J. L., & Lopez, A. D. (1996) · Science · doi:10.1126/science.274.5288.740 · Cited by 2,178
Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A
Lakich, D., Kazazian, H. H., Antonarakis, S. E., & Gitschier, J. (1993) · Nature Genetics · doi:10.1038/ng1193-236 · Cited by 788
Darby, S. C., Kan, S. W., Spooner, R. J., Giangrande, P. L. F., Hill, F. G. H., Hay, C. R. M., Lee, C. A., Ludlam, C. A., & Williams, M. (2007) · Blood · doi:10.1182/blood-2006-10-050435 · Cited by 511
Gringeri, A., Mantovani, L. G., Scalone, L., Mannucci, P. M., & the COCIS Study Group (2003) · Blood · doi:10.1182/blood-2003-03-0941 · Cited by 372
Occurrence of hemophilia in the United States
Soucie, J. M., Evatt, B., Jackson, D., & the Hemophilia Surveillance System Project Investigators (1998) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199812)59:4<288::aid-ajh4>3.0.co;2-i · Cited by 346
A study of variations in the reported haemophilia A prevalence around the world
STONEBRAKER, J. S., BOLTON‐MAGGS, P. H. B., MICHAEL SOUCIE, J., WALKER, I., & BROOKER, M. (2010) · Haemophilia · doi:10.1111/j.1365-2516.2009.02127.x · Cited by 296
Self-citation450 million years of hemostasis
Davidson, C. J., Tuddenham, E. G., & McVey, J. H. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00334.x · Cited by 169
Mortality and causes of death in Italian persons with haemophilia, 1990–2007
TAGLIAFERRI, A., RIVOLTA, G. F., IORIO, A., OLIOVECCHIO, E., MANCUSO, M. E., MORFINI, M., ROCINO, A., MAZZUCCONI, M. G., FRANCHINI, M., & ON BEHALF OF THE ITALIAN ASSOCIATION OF HEMOPHILIA CENTERS (2010) · Haemophilia · doi:10.1111/j.1365-2516.2009.02188.x · Cited by 168
Self-citation
Cited by
Items 201–300 of 535
Wehmeier, U. F., Orth, V., Höppe, V., Valentino, L. A., & Hilberg, T. (2023) · Haemophilia · doi:10.1111/hae.14881 · Cited by 6
Prostate interventions in patients with mild haemophilia: Safe and feasible
Mesnard, B., Drillaud, N., Sigaud, M., Hakim, G., Chelly, S., Ternisien, C., Fouassier, M., Chelghaf, I., Vergie, S. D., Perrouin‐Verbe, M., et al. (2021) · Haemophilia · doi:10.1111/hae.14388 · Cited by 6
Ronsano, J. B. M., Poveda-Andrés, J. L., Romero-Garrido, J. A., García-Barcenilla, S., González-Álvarez, I., Núñez-Vázquez, R. J., Rambla-Pérez, M., & Soto-Ortega, I. (2023) · Farmacia Hospitalaria · doi:10.1016/j.farma.2023.04.002 · Cited by 5
Fujii, T., Ishimura, M., Takao, S., & Deguchi, A. (2024) · Haemophilia · doi:10.1111/hae.15028 · Cited by 5
Russell, C. B., Vettermann, C., Agarwal, S., Witt, E., Clark, W. T., Arens, J., Fronza, R., Obrochta, K. M., Kasprzyk, T., Robinson, T. M., et al. (2025) · Human Gene Therapy · doi:10.1089/hum.2024.236 · Cited by 5
Oldenburg, J., Chambost, H., Liu, H., Hawes, C. R., You, X., Yang, X., Newman, V., Robinson, T. M., Hatswell, A. J., Hinds, D. R., et al. (2024) · Advances in Therapy · doi:10.1007/s12325-024-02834-9 · Cited by 5
Self-citationDebela, M. B., Bekele, K., & Zenbaba, D. (2024) · BMC Public Health · doi:10.1186/s12889-024-20165-w · Cited by 5
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations
Meng, F. (2021) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2021.041 · Cited by 5
Manson, M. A., Zhang, F., Novokhodko, A., Chen, C., Parker, M. H., Loeb, K. R., Kajimoto, M., Campbell, C., Storb, R. F., & Miao, C. H. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021006016 · Cited by 5
Cai, G., Song, L., Chen, G., Yuan, S., Cai, L., Ning, X., Wang, J., & Jiang, W. (2022) · Orthopaedic Surgery · doi:10.1111/os.13457 · Cited by 5
Hepatitis C Virus Infections in Patients with Hemophilia: Links, Risks and Management
Spanoudaki, A., Papadopoulos, N., Trifylli, E.-M., Koustas, E., Vasileiadi, S., & Deutsch, M. J. (2022) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s363177 · Cited by 5
Olasupo, O. O., Nakar, C. T., Haddix, C., Matthew, T., Matino, D., Malec, L. M., Mbuagbaw, L. C. E., Tarride, J., Iorio, A., & Shapiro, A. D. (2023) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2023.102228 · Cited by 5
Self-citationQuon, D. V. K., Wang, J., Wang, M., Pepperell, D., Park, Y. S., Kenet, G., Mahlangu, J. N., Khoo, T., Robinson, T. M., Chavele, K.-M., et al. (2024) · Therapeutic Advances in Hematology · doi:10.1177/20406207241304645 · Cited by 5
Verma, S. P., Tripathi, A. K., Sharma, G. S., Kumar, N., & Kushwaha, R. (2021) · Journal of Hematology and Allied Sciences · doi:10.25259/jhas_13_2021 · Cited by 5
Matino, D., Afraz, S., Zhao, G., Tieu, P. T. M., Gargaro, M., Fallarino, F., & Iorio, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00620 · Cited by 5
Self-citationCalatayud, J., Martín-Cuesta, J., Carrasco, J. J., Pérez‐Alenda, S., Cruz‐Montecinos, C., Andersen, L. L., Querol‐Giner, F., & Casaña, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122587 · Cited by 5
Factor VIII Companion Diagnostic for Haemophilia
Hu, C., Annese, V. F., Giagkoulovits, C., Barrett, M. P., & Cumming, D. R. S. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1006600 · Cited by 5
Transforming hemophilia care: emerging therapeutic innovations and challenges
Huang, K. (2025) · Expert Review of Hematology · doi:10.1080/17474086.2025.2527344 · Cited by 4
Diagnosis and management of hemophilia A and B
Lim, M. Y., Ardila, J., Castaman, G., Dargaud, Y. G., Fijnvandraat, K., Gualtierotti, R., Hermans, C. R. J. R., & Shapiro, S. (2026) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2026.04.005 · Cited by 4
Malec, L. M., Miles, M. E., Amos, L. E., Carlson, S. A., DiMichele, D., Haider, I., James, A., Norris, K. L., Paulyson-Nuñez, K., Recht, M., et al. (2026) · Expert Review of Hematology · doi:10.1080/17474086.2026.2688869 · Cited by 4
Johnsen, J. M., Buckner, T. W., Batsuli, G. M., Carlson, S. A., Cirelli, E. B., DiMichele, D., Flood, V. H., Johnson, A. D., Heiman, M., Kaplan, J., et al. (2026) · Expert Review of Hematology · doi:10.1080/17474086.2026.2688867 · Cited by 4
Bleeding Disorders Research Collaborative: an opportunity for impact
Santaella, M. E. E., Valadez, S., Vázquez, E., Benasutti, H., Carlson, S. A., DiMichele, D., Norris, K. L., Robinson, F., Valentino, L. A., Witkop, M., et al. (2026) · Expert Review of Hematology · doi:10.1080/17474086.2026.2688871 · Cited by 4
Witkop, M., Robinson, F., & DiMichele, D. (2023) · Expert Review of Hematology · doi:10.1080/17474086.2023.2178411 · Cited by 4
Woollacott, I., Chhabra, A., Burke, T., Brownrigg, J. R. W., Richardson, L., Grazzi, E. F., O’Hara, J., Godfrey, J., & Laffan, M. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-11850-y · Cited by 4
Eladnani, R. P., Schaeper, U., Diab, R., Aretz, J., Vrotniakaite-Bajerciene, K., Çaku, S., Yasmin, R., Li, B., Caro, M. D. R., Dames, S., et al. (2025) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2025.03.021 · Cited by 4
Evans, J., Burke, T., Skerrit, M., Santana, I. R., Pietrobelli, T. M. O., Robledo, S., Cavallini, A. G., Neme, D., Khair, K., & Finnegan, A. P. (2025) · Value in Health Regional Issues · doi:10.1016/j.vhri.2025.101167 · Cited by 4
Epidemiological data and treatment strategies in children with severe haemophilia in Italy.
Abbonizio, F., Hassan, H. J., Santagostino, E., Arcieri, R., Biffoni, M., & Giampaolo, A. (2020) · Annali dell Istituto Superiore di Sanità · doi:10.4415/ann_20_04_05 · Cited by 4
The Need for Comprehensive Care for Persons with Chronic Immune Thrombocytopenic Purpura
Ansteatt, K. T., Unzicker, C. J., Hurn, M. L., Olaiya, O., Nugent, D. J., & Tarantino, M. D. (2020) · Journal of Blood Medicine · doi:10.2147/jbm.s289390 · Cited by 4
Periodontal Health and Blood Disorders
Botelho, J., Machado, V., & Mendes, J. J. (2021) · Current Oral Health Reports · doi:10.1007/s40496-021-00301-w · Cited by 4
Wright, T. S., & Cygan, P. H. (2023) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005262 · Cited by 4
Wang, Z., Gu, Y., Wang, R., Xiang, S., Jin, Z., Tong, P., Lv, S., & Liu, X. (2023) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-023-07087-1 · Cited by 4
Defining success in haemophilia care – Are we doing it right?
Srivastava, A. (2024) · Haemophilia · doi:10.1111/hae.14958 · Cited by 4
Bravo, Á. P., Bonilla, R. P., Bardán-Rebollar, D., López‐Jaime, F. J., & Fernandez-Bello, I. (2024) · Clinical Case Reports · doi:10.1002/ccr3.9312 · Cited by 4
Ghosh, S., Tory, S. S., Nazneen, H., Farhad, M. N., Islam, S., Hasan, M. J., & Biswas, A. R. (2024) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-024-00359-9 · Cited by 4
Lipid Nanoparticle-Mediated Liver-Specific Gene Therapy for Hemophilia B
Lohchania, B., Arjunan, P., Mahalingam, G., Dandapani, A., Taneja, P., & Marepally, S. K. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16111427 · Cited by 4
Annualized bleeding rate in hemophilia A patients in Brazil: a systematic review
Prezotti, A., Rocha, D. M. C., Galvão, E. L., Gimenez, T., Sekine, L., Ribeiro, R. A., & Sobreira, E. A. P. (2025) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2025.103736 · Cited by 4
Wu, Y., Sun, S. X., & Fan, T. (2022) · Journal of Blood Medicine · doi:10.2147/jbm.s359510 · Cited by 4
Anazor, F. C., Uthraraj, N. S., Southgate, C., & Dhinsa, B. S. (2023) · Haemophilia · doi:10.1111/hae.14770 · Cited by 4
Damoctocog Alfa Pegol for Hemophilia A Prophylaxis: An Italian Multicenter Survey
Zanon, E. (2023) · Pharmaceuticals · doi:10.3390/ph16091195 · Cited by 4
Coyle, C. W., Knight, K. A., Brown, H. C., George, S., Denning, G., Branella, G. M., Childers, K. C., Spiegel, P. C., Spencer, H. T., & Doering, C. B. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.11.010 · Cited by 4
Stonebraker, J. S., & Ducore, J. M. (2020) · Haemophilia · doi:10.1111/hae.14159 · Cited by 4
Self-citationHemofilia A: una enfermedad huérfana
Pacheco, V. S., & Vizcaíno-Carruyo, J. C. (2021) · Medicina y Laboratorio · doi:10.36384/01232576.452 · Cited by 4
McCarley, S. C., Murphy, D., Thompson, J., & Shovlin, C. L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12247710 · Cited by 4
Emerging drugs for hemophilia A: insights into phase II and III clinical trials
Kızılocak, H., & Young, G. A. (2021) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2021.1988073 · Cited by 4
Irsara, C., Griesmacher, A., Strasser, B., Schlagenhauf, A., Sorschag, C., Wimmer, E., Prüller, F., Cadamuro, J., Radek, J., Tomasits, J., et al. (2025) · Hämostaseologie · doi:10.1055/a-2599-9908 · Cited by 3
Yang, Y., Zhang, J., Chen, L., Dong, H., Sun, T., Dai, X., Ju, M., Liu, W., Chen, Y., Liu, X. F., et al. (2025) · Hematology · doi:10.1080/16078454.2025.2564511 · Cited by 3
Physical Activity in People with Hemophilia
Cruz‐Montecinos, C., Joaquin, C., Andersen, L. L., Daffunchio, C., Soto, V., López, M., Pérez‐Alenda, S., Chimeno‐Hernández, A., Stephensen, D., & Núñez-Cortés, R. (2025) · Seminars in Thrombosis and Hemostasis · doi:10.1055/a-2778-9890 · Cited by 3
Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B
Olasupo, O. O., Noronha, N., Lowe, M. S., Ansel, D., Bhatt, M., & Matino, D. (2026) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014544.pub3 · Cited by 3
Neurological Complications Associated with Hereditary Bleeding Disorders
Bhatti, M. Q., Gonzalez‐Fernandez, E., Bhatia, K., Divani, A. A., Napoli, M. D., Hinduja, A., & Datta, Y. H. (2023) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-023-01313-y · Cited by 3
Report on the diagnosis and treatment of hemophilia in China (Version 2024)
Xue, F., Dai, J., Chen, L., Liu, W., Zhang, H.-Q., Wu, R., Sun, J., Zhang, X., Wu, J., Zhao, Y., et al. (2024) · LabMed discovery. · doi:10.1016/j.lmd.2024.100007 · Cited by 3
Zhou, Y., Li, Z., Liu, G., Chen, Z., Yao, W., Li, G., Zhen, Y., Cheng, X., Ai, D., Huang, K., et al. (2024) · Clinical Therapeutics · doi:10.1016/j.clinthera.2024.09.003 · Cited by 3
Pinelli, E., Valdré, L., Piscitelli, L., Senesi, G., Massini, M. S., Guarino, V., Cavalieri, I. D., Barone, G., Zinno, R., Benedetti, M. G., et al. (2025) · BMJ Open Sport & Exercise Medicine · doi:10.1136/bmjsem-2025-002494 · Cited by 3
Srivastava, V., Liu, Z., Wei, W., Zhang, Y., Paton, J. C., Paton, A. W., Mu, T., & Zhang, B. (2025) · Biomolecules · doi:10.3390/biom15040458 · Cited by 3
Hemophilia A: An Ideal Disease for Prenatal Therapy
Porada, C. D., Atala, A., & Almeida-Porada, G. D. (2025) · Prenatal Diagnosis · doi:10.1002/pd.6833 · Cited by 3
The use of rIX-FP in patients with haemophilia B: a nurse's perspective
Garner, K., Guelcher, C., & Pollard, D. (2021) · The Journal of Haemophilia Practice · doi:10.17225/jhp00180 · Cited by 3
Non-clotting factor therapies for preventing bleeds in people with hemophilia
Olasupo, O. O., Noronha, N., Lowe, M. S., Ansel, D., Bhatt, M. D., & Matino, D. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014544 · Cited by 3
“I didn’t know women could have haemophilia”: A qualitative case study
Fletcher, S. (2022) · The Journal of Haemophilia Practice · doi:10.2478/jhp-2022-0011 · Cited by 3
Nemes, A., Kormányos, Á., Vezendi, K., Marton, I., & Borbényi, Z. (2022) · Journal of Cardiovascular Echography · doi:10.4103/jcecho.jcecho_19_22 · Cited by 3
Hagembe, J., Baumann, A., Haffar, A., Pierce, G. F., & Toulon, P. A. (2023) · Haemophilia · doi:10.1111/hae.14739 · Cited by 3
Ronsano, J. B. M., Poveda-Andrés, J. L., Romero-Garrido, J. A., García-Barcenilla, S., González-Álvarez, I., Núñez-Vázquez, R. J., Rambla-Pérez, M., & Soto-Ortega, I. (2023) · Farmacia Hospitalaria · doi:10.1016/j.farma.2023.01.003 · Cited by 3
Hemophilia in Jordan: An Economic Burden Dilemma of Rare Disease
Alabbadi, I., Abbadi, A. K. A. O. A., Daher, A. H., BaniHani, A., & Awidi, A. S. (2023) · Jordan Journal of Pharmaceutical Sciences · doi:10.35516/jjps.v16i2.1462 · Cited by 3
Hagembe, J., Baumann, A., Santaella, M. E. E., Sannié, T., Lambert, C., Cruickshank, A. L., Gaitan‐Fitch, C., Suwantaroj, E., Garrido, C., & Mekhuzla, S. (2023) · Haemophilia · doi:10.1111/hae.14862 · Cited by 3
Rare within Rare: A Girl with Severe Haemophilia A and Turner Syndrome
Blag, C. L., Şerban, M., Ursu, C. E., Popa, C., Trăilă, A., Jinca, C. M., Tomuleasa, C., Bota, M., Ioniță, I., & Arghirescu, T. S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12237437 · Cited by 3
Yu, J. K., Iorio, A., Chelle, P., & Edginton, A. N. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.10.023 · Cited by 3
Self-citationSannié, T., de Moerloose, P., & AFATH (2021) · Haemophilia · doi:10.1111/hae.14269 · Cited by 3
Perfil da hemofilia no estado de São Paulo - Brasil
Guersoni, A. C. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2022.tde-18042022-132318 · Cited by 3
Prevalence and Incidence of Hemophilia in the US
Dave, P. (2024) · Asian Journal of Hospital Pharmacy · doi:10.38022/ajhp.v4i2.85 · Cited by 2
Patient and Caregiver Preferences for Hemophilia A Treatment in Taiwan: A Discrete Choice Experiment
Chiou, S., Weng, T.-F., & Wang, J. (2024) · Value in Health Regional Issues · doi:10.1016/j.vhri.2024.101035 · Cited by 2
Haemophilia care in Iraq; a multi-centre study
Al-Rahal, N. K., Hassan, M. K., Abid, O., & Mohsin, A. M. (2024) · Journal of the Pakistan Medical Association · doi:10.47391/jpma-bagh-16-20 · Cited by 2
McLaughlin, P., la Corte‐Rodríguez, H. D., Burke, T., Nissen, F., Aizenas, M., Moreno, K., & O’Hara, J. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03514-1 · Cited by 2
Khair, K., Nagra, R., Gorman, R., Fletcher, S., Jenner, K., Trim, J., & Collings, S. (2025) · The Journal of Haemophilia Practice · doi:10.2478/jhp-2025-0001 · Cited by 2
Chen, L., Lin, S., Zhou, W., Ling, Y., Shi, Z., Ge, Q., Liu, W., Li, J., Tong, P., Li, H., et al. (2025) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-025-08919-y · Cited by 2
Vishnu, P., & Aboulafia, D. M. (2025) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2025.07.010 · Cited by 2
Acupuncture for Chronic Pain Management in Haemophilic Arthropathy: A Systematic Review
Demeco, A., Gusai, M., Masi, M., Frizziero, A., & Costantino, C. (2025) · Haemophilia · doi:10.1111/hae.70109 · Cited by 2
Luo, F., Hu, Y., Wang, Y., Luo, D., Chen, T., & Yu, D. (2025) · Haemophilia · doi:10.1111/hae.70093 · Cited by 2
Douglas, T. G., Santos, S., Hinds, D. R., Hatswell, A. J., & Taylor, K. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03339-9 · Cited by 2
Dou, D., Lü, J., Sangchen, P., Guo, C., Li, D., He, F., Zhu, X., Zhang, X., & Chen, X. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00918 · Cited by 2
Dou, D., Lü, J., Li, D., He, F., Zhu, X., Zhang, X., & Chen, X. (2025) · Pharmaceutical Research · doi:10.1007/s11095-025-03918-z · Cited by 2
Nguyen, K. T., Bakeer, N., von Drygalski, A., Babyn, P., Pergantou, H., Dunn, A. L., Lundin, B., & Strike, K. (2025) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2025.103185 · Cited by 2
Ye, J., & Huang, K. (2025) · Annals of Hematology · doi:10.1007/s00277-025-06723-1 · Cited by 2
Liver dysfunction in AAV-mediated Hemophilia B gene therapy: Mechanisms and management strategies
Song, X., Ding, B., Jia, H., & Zhou, H. (2025) · Blood Reviews · doi:10.1016/j.blre.2025.101356 · Cited by 2
Nine areas with outstanding challenges for hemophilia B research
Astermark, J., Hermans, C. R. J. R., Lenting, P. J., O’Donnell, J. S., & Tank, O. B. O. T. F. T. (2026) · Therapeutic Advances in Hematology · doi:10.1177/20406207251409300 · Cited by 2
Lorenz, A., Tomschi, F., Schmidt, A., Stephan, H., WIESE, J., & Hilberg, T. (2026) · Healthcare · doi:10.3390/healthcare14030368 · Cited by 2
Algarni, A. (2026) · Haemophilia · doi:10.1111/hae.70247 · Cited by 2
Regional variations and trends in hemophilia prevalence: A global analysis with future projection
Mothashin, M., Hossain, G., Barmon, S. C., Dipu, M. H., Saqlain, M. M., & Mamun, A. S. M. A. (2026) · PLOS Global Public Health · doi:10.1371/journal.pgph.0006098 · Cited by 2
The therapeutic landscape of inherited bleeding disorders in China
Wang, Y., Xue, F., Poon, M., & Yang, R. (2026) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2026.103460 · Cited by 2
Ndadza, A., & Mahlangu, J. N. (2026) · Blood Global Hematology · doi:10.1016/j.bglo.2026.100089 · Cited by 2
Chopra, P., Singh, M., Singh, A., Masi, A., Yurkofsky, J., Zaita, B., & Kaur, G. (2023) · Cureus · doi:10.7759/cureus.43485 · Cited by 2
Hemostasis in primary care: A primer
Todd, K. (2025) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2025.101762 · Cited by 2
Hsieh, M. H., Chiou, S., Liao, T., Yang, Y. K., & Lai, E. C. (2021) · Haemophilia · doi:10.1111/hae.14250 · Cited by 2
Kinai, E., Ono, M., Oh, A., Ota, M., Miyaguchi, Y., & Ueda, H. (2022) · Health Science Reports · doi:10.1002/hsr2.498 · Cited by 2
Baglo, T., Zohoun, A., Azonbakin, S. A., Houssou, B., Massi, R. M., Guiwa, C. O., Anani, L., Gazard, D. K., & Touré, A. O. (2023) · International Blood Research & Reviews · doi:10.9734/ibrr/2023/v14i4324 · Cited by 2
Ho, S. K. L., Ng, S. Y. L., Yung, T., Mok, M. T. S., Yiu, W., Cheng, H. H. Y., Cheng, S. S. W., Luk, H., Lo, I. F. M., & Kan, A. S. Y. (2024) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63657 · Cited by 2
Kisakye, A., Kasirye, P., Muramuzi, D., Opuch, D., Nampiima, J., Ndeezi, G., Yeka, A., & Vultur, H. (2023) · The Journal of Haemophilia Practice · doi:10.2478/jhp-2023-0018 · Cited by 2
Ucero‐Lozano, R., Pérez‐Llanes, R., Cuesta‐Barriuso, R., & Donoso‐Úbeda, E. (2024) · Journal of Rehabilitation Medicine · doi:10.2340/jrm.v56.40775 · Cited by 2
Kengkla, K., Wilairat, P., Natesirinilkul, R., Sosothikul, D., Phisalprapa, P., & Saokaew, S. (2024) · Haemophilia · doi:10.1111/hae.15105 · Cited by 2
Determining causes of death among individuals with haemophilia in Afghanistan
Mousavi, S. H., Arif, S., Madadi, S., & Mansouritorghabeh, H. (2021) · Haemophilia · doi:10.1111/hae.14462 · Cited by 2
Pace, L. M., Lee, A. Y., Nath, S., & Alviedo, N. (2021) · Cureus · doi:10.7759/cureus.20352 · Cited by 2
Sasanakul, W., Chuansumrit, A., Sirachainan, N., & Kadegasem, P. (2022) · The Application of Clinical Genetics · doi:10.2147/tacg.s363132 · Cited by 2
Successful Spinal Cord Stimulator Implantation in a Patient with Hemophilia A: A Case Report
Woo, S., Kim, D. H., Kim, Y. C., & Yoo, Y. (2022) · International journal of Pain · doi:10.56718/ijp.22-015 · Cited by 2
Metadata
- Authors
- Iorio, A., Stonebraker, J. S., Chambost, H., Makris, M., Coffin, D., Herr, C., Germini, F., & for the Data and Demographics Committee of the World Federation of Hemophilia*
- Affiliations
- McMaster University (CA)
- North Carolina State University (US)
- La Timone Hospital of Assistance Publique – Hôpitaux de Marseille, Aix-Marseille University, Institut National de la Santé et de la Recherche Médicale, and Institut National de la Recherche Agronomique, Marseille, France (H.C.)
- University of Sheffield (GB)
- World Federation of Hemophilia (CA)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2019-10-15
- Volume
- 171
- Issue
- 8
- Pages
- 540-546
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2972722566
- Cited by
- 462
- References
- 45
- Citations by year
- 2026: 57 · 2025: 76 · 2024: 80 · 2023: 71 · 2022: 75 · 2021: 64 · 2020: 34 · 2019: 4
- FWCI
- 7.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- Annals of Internal Medicine
- Topics
- Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Keywords
- hemophilia, hemophilia A, hemophilia B, prevalence, life expectancy, disease burden, severe hemophilia, years of life lost
- MeSH terms
- Australia, Canada, France, United Kingdom, Hemophilia A, Humans, Infant, Newborn, Italy, Life Expectancy, Male, New Zealand, Registries, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.